NG
NVO

NatWest Group’s Novo Nordisk NVO Stock Holding History

NatWest Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-7,664
Closed -$204K – 415
2015
Q1 		$204K Sell
7,664
-7,566
-50% -$174K ﹤0.01% 419
2014
Q4 		$323 Sell
15,230
-2,000
-12% -$44.7K ﹤0.01% 367
2014
Q3 		$411 Hold
17,230
– – ﹤0.01% 380
2014
Q2 		$398K Buy
17,230
+1,830
+12% +$40.4K 0.02% 382
2014
Q1 		$352K Hold
15,400
– – 0.02% 405
2013
Q4 		$285K Buy
+15,400
New +$268K 0.01% 665

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

NatWest Group's NVO Position: Q2 2015 in Review

NatWest Group sold out of Novo Nordisk (NVO) in Q2 2015, closing a stake of 7,664 shares — an estimated $204K sold.

NatWest Group first reported a position in NVO in Q4 2013 and held it in 6 quarters. The position peaked at $398K in Q2 2014. 516 funds tracked by Wall St. Rank hold NVO as of Q2 2015.

  • NatWest Group reported no remaining Novo Nordisk position as of Q2 2015 after selling out during the quarter.
  • NatWest Group sold 7,664 Novo Nordisk shares in Q2 2015, an estimated $204K.
  • NatWest Group first reported a position in Novo Nordisk in Q4 2013 and held it in 6 quarters.
  • NatWest Group's Novo Nordisk position peaked at $398K in Q2 2014.
  • 516 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2015.

Based on NatWest Group's 13F filing for Q2 2015, filed 6 Aug 2015.